Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib and HDM201 in Advanced Colorectal Cancer
NCT03714958Phase 1Completed
- Sponsor
- Centre Léon Bérard
- Start
- Dec 2018
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of siremadlin in colorectal cancer (CRC), sponsored by Centre Léon Bérard. Primary endpoint: Maximum Tolerated Dose at Cycle 2. Started Dec 2018; status: completed.
02
Drugs
siremadlin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03714958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03714958.